Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The search for neuroprotective strategies in stroke.

Literature DB >> 14970016

The search for neuroprotective strategies in stroke.

Gary H Danton¹, W Dalton Dietrich.

Abstract

Entities: Disease

Mesh：

Substances：
Neuroprotective Agents

Year: 2004 PMID： 14970016 PMCID： PMC7974603

Source DB: PubMed Journal: AJNR Am J Neuroradiol ISSN： 0195-6108 Impact factor: 3.825

× No keyword cloud information.

158 in total

1. Mapping the ischaemic penumbra with PET: a new approach.

Authors: J C Baron
Journal: Brain Date: 2001-01 Impact factor: 13.501

Review 2. Neuroprotection in cerebrovascular disease.

Authors: K K Jain
Journal: Expert Opin Investig Drugs Date: 2000-04 Impact factor: 6.206

3. Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: a microdialysis study.

Authors: Christian Berger; Wolf-Rüdiger Schäbitz; Dimitrios Georgiadis; Thorsten Steiner; Alfred Aschoff; Stefan Schwab
Journal: Stroke Date: 2002-02 Impact factor: 7.914

4. Thresholds in cerebral ischemia - the ischemic penumbra.

Authors: J Astrup; B K Siesjö; L Symon
Journal: Stroke Date: 1981 Nov-Dec Impact factor: 7.914

5. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke.

Authors: E S Connolly; C J Winfree; C J Prestigiacomo; S C Kim; T F Choudhri; B L Hoh; Y Naka; R A Solomon; D J Pinsky
Journal: Circ Res Date: 1997-09 Impact factor: 17.367

Review 6. The effect of nimodipine on the evolution of human cerebral infarction studied by PET.

Authors: A M Hakim; A C Evans; L Berger; H Kuwabara; K Worsley; G Marchal; C Biel; R Pokrupa; M Diksic; E Meyer
Journal: J Cereb Blood Flow Metab Date: 1989-08 Impact factor: 6.200

7. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology.

Authors: K Takagi; M D Ginsberg; M Y Globus; W D Dietrich; E Martinez; S Kraydieh; R Busto
Journal: J Cereb Blood Flow Metab Date: 1993-07 Impact factor: 6.200

8. Dantrolene protects against ischemic, delayed neuronal death in gerbil brain.

Authors: L Zhang; Y Andou; S Masuda; A Mitani; K Kataoka
Journal: Neurosci Lett Date: 1993-08-06 Impact factor: 3.046

9. Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.

Authors: M Takahashi; J W Ni; S Kawasaki-Yatsugi; T Toya; C Ichiki; S I Yatsugi; K Koshiya; M Shimizu-Sasamata; T Yamaguchi
Journal: J Pharmacol Exp Ther Date: 1998-11 Impact factor: 4.030

10. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502.

Authors: Eileen McCracken; Jill H Fowler; Deborah Dewar; Steve Morrison; James McCulloch
Journal: J Cereb Blood Flow Metab Date: 2002-09 Impact factor: 6.200

14 in total

Review 1. Evaluation of combination therapy in animal models of cerebral ischemia.

Authors: Victoria E O'Collins; Malcolm R Macleod; Geoffrey A Donnan; David W Howells
Journal: J Cereb Blood Flow Metab Date: 2012-02-01 Impact factor: 6.200

Review 2. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors: Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal: J Cereb Blood Flow Metab Date: 2006-10-18 Impact factor: 6.200

Review 3. Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.

Authors: Victoria E O'Collins; Malcolm R Macleod; Susan F Cox; Leena Van Raay; Elena Aleksoska; Geoffrey A Donnan; David W Howells
Journal: J Cereb Blood Flow Metab Date: 2010-10-27 Impact factor: 6.200

The search for neuroprotective strategies in stroke.

1. Mapping the ischaemic penumbra with PET: a new approach.

Review 2. Neuroprotection in cerebrovascular disease.

3. Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: a microdialysis study.

4. Thresholds in cerebral ischemia - the ischemic penumbra.

5. Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke.

Review 6. The effect of nimodipine on the evolution of human cerebral infarction studied by PET.

7. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology.

8. Dantrolene protects against ischemic, delayed neuronal death in gerbil brain.

9. Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.

10. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502.

Review 1. Evaluation of combination therapy in animal models of cerebral ischemia.

Review 2. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Review 3. Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.

Review 4. Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection.

Review 5. Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke.

6. Neuroprotective effects of bilobalide are accompanied by a reduction of ischemia-induced glutamate release in vivo.

7. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.

8. Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside.

9. Pharmacological and non-pharmacological recanalization strategies in acute ischemic stroke.

10. Recombinant human erythropoietin increases cerebral cortical width index and neurogenesis following ischemic stroke.